GlassScriptPhysician profile
Elaine Lee
NPI 1619243086
$4,223.69
in general payments reported to CMS, 2019-2025
52 companies · $645 in 2025
The $645 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $405 · 2022: $939 · 2023: $1,668 · 2024: $566 · 2025: $645.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,839 · Entertainment: $40.79.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,838.89 |
| Entertainment | $40.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $446.97 | 2021-2024 | Enhertu, Lynparza, Imfinzi |
| Merck Sharp & Dohme LLC | $365.15 | 2021-2025 | Keytruda, Lynparza |
| Myriad Genetic Laboratories, INC. | $338.04 | 2023 | Prolaris, Precisetumor, Myrisk |
| Janssen Biotech, INC. | $244.76 | 2021-2024 | Imbruvica, Darzalex, Erleada |
| Amgen INC. | $201.26 | 2021-2023 | Blincyto, Kyprolis, Lumakras |
| Takeda Pharmaceuticals U.S.A., INC. | $191.85 | 2021-2024 | Ninlaro, Alunbrig, Iclusig |
| Leica Microsystems INC. | $190.00 | 2023 | |
| Seagen INC. | $174.52 | 2021-2023 | Padcev |
| Medical Device Business Services, INC. | $137.51 | 2023 | Vistaseal |
| Novartis Pharmaceuticals Corporation | $124.60 | 2021-2025 | |
| Tactile Systems Technology INC | $114.27 | 2023 | Flexitouch Plus, Entre Plus |
| Trevena, INC. | $97.22 | 2022 | |
| Eisai INC. | $89.00 | 2025 | |
| Smith+Nephew, INC. | $85.10 | 2025 | Stravix, Grafix |
| Regeneron Healthcare Solutions, INC. | $81.55 | 2021-2024 | Libtayo |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $73.55 | 2022-2025 | Enhertu |
| Dilon Technologies, INC. | $71.43 | 2025 | Hemoblast Bellows |
| Endomagnetics LTD | $67.43 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $66.95 | 2021-2023 | |
| Incyte Corporation | $58.53 | 2023-2025 | Jakafi, Monjuvi |
| Taiho Oncology, INC. | $56.45 | 2022-2023 | |
| Genentech USA, INC. | $55.33 | 2023 | Venclexta, Perjeta, Phesgo |
| Bioptics, INC. | $53.30 | 2022 | |
| Abbvie INC. | $50.23 | 2024-2025 | |
| Emd Serono, INC. | $47.79 | 2022-2024 | |
| Lilly USA, LLC | $43.96 | 2023 | Jaypirca |
| Pharmacyclics LLC, An Abbvie Company | $43.59 | 2022 | |
| Deciphera Pharmaceuticals INC. | $41.78 | 2023-2024 | Qinlock |
| Kub Technologies INC. | $40.79 | 2023 | Mozart |
| Ethicon US, LLC | $33.33 | 2023 | Dermabond Prineo |
| Dendreon Pharmaceuticals LLC | $33.28 | 2022 | |
| Genzyme Corporation | $32.94 | 2022 | |
| Coherus Oncology, INC. | $32.84 | 2025 | Loqtorzi |
| Rigel Pharmaceuticals, INC. | $30.11 | 2022-2023 | Tavalisse, Rezlidhia |
| Glaxosmithkline, LLC. | $29.72 | 2022 | |
| Mylan Institutional INC. | $27.95 | 2022 | |
| Avanos Medical | $27.78 | 2023 | On-Q* Pump and Accessories |
| Myovant Sciences INC. | $27.57 | 2022 | |
| Pfizer INC. | $26.27 | 2024 | |
| Acceleron Pharma, INC. | $24.99 | 2021 | |
| Agios Pharmaceuticals, INC. | $24.89 | 2024 | Pyrukynd |
| Vertex Pharmaceuticals Incorporated | $24.60 | 2025 | |
| Tersera Therapeutics LLC | $24.50 | 2025 | Zoladex |
| Beigene USA, INC. | $23.90 | 2025 | Brukinsa |
| Sobi, INC | $23.26 | 2022 | |
| Recordati_rare_diseases_inc. | $21.90 | 2024 | Sylvant |
| Cardinal Health 414 LLC | $20.14 | 2024 | Kit For The Preparation of Lymphoseek (Technetium Tc 99m Tilmanocept) |
| Biotissue Holdings INC. | $18.02 | 2025 | |
| Blue Earth Diagnostics | $17.15 | 2022 | |
| Elucent Medical | $17.13 | 2025 | |
| Kyowa Kirin, INC. | $15.94 | 2022 | |
| Janssen Pharmaceuticals, INC | $12.57 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elaine Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.